| Disease | hypophosphatemia |
| Phenotype | C0023470|myeloid leukemia |
| Sentences | 1 |
| PubMedID- 26155363 | Vegfr and pdgfr inhibitors would seem a therapeutic potential for our case, but as imatinib, a potent inhibitor of pdgfr, has been associated with severe hypophosphatemia in patients with chronic myeloid leukemia (13), we were reluctant to proceed with this therapeutic approach. |
Page: 1